Evidence map›Paper›PMID 41417454›Full record

ReviewRevista medica del Instituto Mexicano del Seguro Social2026

[Rh blood group: Review and importance of genotyping].

Esmeralda Campos-Aguirre, María Fernanda Mendoza-Rangel, Juan Rodríguez-Silverio, Gamaliel Benítez-Arvizu

Abstract readEnglish AbstractReview
In one paragraph

Review in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Esmeralda Campos-AguirreInstituto Politécnico Nacional, Escuela Superior de Medicina, Doctorado en Investigación en Medicina. Ciudad de México, México.ORCID 0000-0002-9013-4701
María Fernanda Mendoza-RangelInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Banco de Sangre, Patología Clínica. Ciudad de México, México.ORCID 0009-0005-1616-4215
Juan Rodríguez-SilverioInstituto Politécnico Nacional, Escuela Superior de Medicina, Doctorado en Investigación en Medicina. Ciudad de México, México.ORCID 0000-0002-8998-1196
Gamaliel Benítez-ArvizuInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Banco de Sangre, Patología Clínica. Ciudad de México, México.ORCID 0000-0001-6065-7176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rh antigen is a transmembrane protein whose presence or absence is genetically inherited in humans. The genetic expression is controlled by 2 closely linked genes. The expression of the group (the antigen) can be modified by mutations or deletions in the gene that encodes it, leading to discrepancies that can sometimes only be resolved with molecular testing; such is the case of people with weak or partial expression of the D antigen. Since the antibodies of Rh blood group are not spontaneous and are linked to both the possibility of developing hemolytic disease of the newborn and severe transfusion reactions, the administration of anti-D immunoglobulin has been implemented as a risk reduction measure. In developed countries, genotyping methods are used to guide the administration of this vaccine, since, as a product of human origin, its availability is often not the same in all areas where it is required. Understanding the characteristics that distinguish the antigens of this blood group helps us move toward the use of higher-resolution determination methods that allow us to increase blood safety in our patients.

Indexed as

Genotyping TechniquesRh-Hr Blood-Group SystemGenotypeHumansRh-Hr Blood-Group SystemAntígenos de Grupos SanguíneosBlood Group AntigensIsoinmunización RhMolecular Diagnostic TechniquesRh-Hr Blood-Group SystemRh IsoimmunizationSistema de Grupo Sanguíneo Rh-HrTécnicas de Diagnóstico Molecular

Identifiers

PMID41417454
PMCPMC12768421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.